BioPhonics

Curated by Signal

Provider of AI-based stethoscope for diagnosis of heart and lung disease

Overview

BioPhonics provides an AI-based stethoscope for diagnosis of heart and lung disease. It provides machine learning techniques to detect murmurs and diagnose valvular heart disease.

Key facts

Founded: 2018
Headquarters: United Kingdom
Stage: Sign up to view
Industry: Health Technology

Business model

2 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

The AbedGraham Group
Provider of clinical security analytics platform for healthcare professionals
Health TechnologyLondon, United Kingdom
Unicorn
Provider of health related contents & blogging platform for health & wellness
Health TechnologyManchester, United Kingdom
Healthya
Mobile-based application for management of health records
Health TechnologyBolton, United Kingdom

About BioPhonics

What does BioPhonics do?

BioPhonics provides an AI-based stethoscope for diagnosis of heart and lung disease.

Where is BioPhonics headquartered?

BioPhonics is headquartered in United Kingdom.

When was BioPhonics founded?

BioPhonics was founded in 2018.

Which sector is BioPhonics in?

BioPhonics operates in Health Technology.

Who are BioPhonics's competitors?

Companies similar to BioPhonics include The AbedGraham Group, Unicorn, and Healthya.